Joshua M. Moss Joins the SenesTech Board of Directors
SenesTech, Inc. (NASDAQ: SNES), a leader in humane pest control solutions, is thrilled to announce the appointment of Joshua M. Moss to its Board of Directors. His extensive background in investment management and strategic growth is expected to bring valuable insights into the company's future endeavors.
Professional Background of Joshua M. Moss
Joshua M. Moss serves as the co-founder, Managing Director, and Portfolio Manager at EAM Global Investors, an investment firm known for specializing in non-U.S. and emerging market equities, managing approximately $3 billion in assets. Bringing over 20 years of experience in institutional investment, Josh has a distinguished record in optimizing portfolio performance and leading teams to success.
Significant Achievements in Finance
Joshua’s career commenced at Credit Suisse, where he honed his skills in investment banking and equity research. He also held key positions at Allianz Global Investors, successfully managing substantial portfolios and overseeing sector teams. At his firm, he was pivotal in launching various strategies, including International Small Cap and Emerging Markets Small Cap options, showcasing his adeptness in identifying growth opportunities.
Academic Credentials and Expertise
With a solid educational foundation, Josh holds an MBA in Finance from UCLA Anderson School of Management and a BA in History from the University of California, San Diego. Residing in San Diego, he speaks fluent Spanish and leverages his market knowledge to enhance investment strategies focused on sustained growth and resilience.
Joshua's Vision for SenesTech
Expressing his enthusiasm, Mr. Moss stated, "SenesTech – and Evolve – are poised for growth this coming year and beyond, and I look forward to contributing to that growth and success. We have the right team and the right product." His confidence highlights the company’s trajectory toward success and innovation in humane pest control technologies.
About SenesTech
SenesTech is devoted to fostering healthier environments by using humane methods to manage pest populations via fertility control. As experts in this field, they have developed groundbreaking products such as ContraPest, the only EPA-registered contraceptive for rats, and Evolve, a minimum-risk contraceptive soft bait. These innovations are tailored to enhance the effectiveness of pest management strategies while minimizing reliance on traditional poisons, paving the way for sustainable and humane solutions.
Commitment to Sustainable Pest Management
SenesTech’s mission goes beyond business; they aim to create cleaner urban spaces, efficient enterprises, and content households through their cutting-edge product offerings. By integrating their technologies into existing pest control programs, they significantly uplift the standards of pest management solutions globally.
Contact Information
For further inquiries, you can contact:
Investors:
Robert Blum, Lytham Partners, LLC
(602) 889-9700
Marketing:
Rochelle Paulet, Director of Marketing, SenesTech, Inc.
(303) 416-0032
Frequently Asked Questions
What role will Joshua M. Moss play at SenesTech?
Joshua M. Moss will serve on the Board of Directors, contributing to strategic decisions and company growth.
What is the focus of SenesTech's pest control products?
SenesTech specializes in humane pest management through fertility control, offering solutions that are innovative and environmentally friendly.
How does SenesTech's approach differ from traditional pest control?
Unlike traditional methods that often rely on poisons, SenesTech promotes humane and sustainable strategies that manage pest populations through fertility control.
What is ContraPest?
ContraPest is the only EPA-registered contraceptive designed for use in pest control, specifically effective on both male and female rats.
What are the future growth prospects for SenesTech?
The company, with its innovative products and robust leadership, is well-positioned for significant growth in the upcoming years.
